| scholarly article | Q13442814 |
| P50 | author | Jan H Cornel | Q91960546 |
| Frans A L van der Horst | Q96680345 | ||
| Arend Mosterd | Q97594396 | ||
| P2093 | author name string | Dominique de Kleijn | |
| Willem A Bax | |||
| Aernoud T L Fiolet | |||
| Max J M Silvis | |||
| Tjerk S J Opstal | |||
| P2860 | cites work | Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction | Q91304576 |
| The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction | Q91711850 | ||
| Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial | Q92351085 | ||
| Low-Dose Methotrexate for the Prevention of Atherosclerotic Events | Q92980641 | ||
| Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study | Q46802784 | ||
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
| Colchicine toxicity in end-stage renal disease patients: a case-control study | Q47288576 | ||
| Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond | Q47599422 | ||
| Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study | Q47620876 | ||
| Colchicine: 1998 update. | Q53352157 | ||
| Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) | Q57182634 | ||
| Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial | Q58375651 | ||
| Colchicine in Stable Coronary Artery Disease | Q58615940 | ||
| Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study | Q64125981 | ||
| Long-term colchicine prophylaxis in familial Mediterranean fever | Q67692370 | ||
| Polymorphonuclear leukocyte motility in vitro. IV. colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals | Q71491725 | ||
| Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment | Q72099809 | ||
| Alteration of microtubule polymerization modulates arteriolar vasomotor tone | Q78009247 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data | Q28742740 | ||
| NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 | ||
| Inflammation in atherosclerosis: from pathophysiology to practice | Q33709505 | ||
| Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension | Q35219093 | ||
| The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis | Q35864053 | ||
| Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome | Q36141649 | ||
| Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis | Q36287541 | ||
| Colchicine today | Q36635754 | ||
| Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. | Q37070180 | ||
| Colchicine: its mechanism of action and efficacy in crystal-induced inflammation | Q37220559 | ||
| Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims | Q37308677 | ||
| Colchicine update: 2008. | Q37313632 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation | Q37814575 | ||
| Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
| Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque | Q38679802 | ||
| Inflammasomes: mechanism of assembly, regulation and signalling | Q38862650 | ||
| Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease | Q43447839 | ||
| Low-dose colchicine for secondary prevention of cardiovascular disease | Q46245044 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P921 | main subject | coronary artery disease | Q844935 |
| biomarker | Q864574 | ||
| (S)-(−)-colchicine | Q326224 | ||
| P304 | page(s) | e0237665 | |
| P577 | publication date | 2020-08-31 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein | |
| P478 | volume | 15 |
Search more.